Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNABII family consists mainly of IHF and HU—highly conserved nucleoid-associated proteins essential for both intracellular chromosome organization and extracellular stabilization of pathogenic bacterial biofilms. Their unique role makes them prime targets for novel anti-biofilm therapies with broad-spectrum potential against diverse bacteria. DNABII proteins are universally conserved among eubacteria but have no known homologs in mammalian species. Even when primary sequence homology varies between species, their secondary structure—and thus function—remains highly conserved. This makes them attractive targets for broad-spectrum anti-biofilm strategies.
Disruption of biofilm structure by destabilizing the eDNA lattice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNABII Family of Bacterial DNA-Binding Proteins (DNABII).